Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion.

Although the hyperdiploid subgroup showed the best overall survival, this difference did not reach statistical significance ( P =0.3619) ( Figure 3a ).

also in 111,027 other papers